Quantitative gait and balance outcomes for ataxia trials: consensus recommendations by the ataxia global initiative working group on digital-motor biomarkers

W Ilg, S Milne, T Schmitz-Hübsch, L Alcock, L Beichert… - The Cerebellum, 2024 - Springer
With disease-modifying drugs on the horizon for degenerative ataxias, ecologically valid,
finely granulated, digital health measures are highly warranted to augment clinical and …

The global patient-reported outcomes for multiple sclerosis initiative: bridging the gap between clinical research and care–updates at the 2023 plenary event

P Zaratin, S Samadzadeh, M Seferoğlu… - Frontiers in …, 2024 - frontiersin.org
Significant advancements have been achieved in delineating the progress of the Global
PROMS (PROMS) Initiative. The PROMS Initiative, a collaborative endeavor by the …

Mobilise-D insights to estimate real-world walking speed in multiple conditions with a wearable device

C Kirk, A Küderle, ME Micó-Amigo, T Bonci… - Scientific reports, 2024 - nature.com
This study aimed to validate a wearable device's walking speed estimation pipeline,
considering complexity, speed, and walking bout duration. The goal was to provide …

Clinical benefit of MAO-B and COMT inhibition in Parkinson's disease: practical considerations

M Regensburger, CW Ip, Z Kohl, C Schrader… - Journal of Neural …, 2023 - Springer
Inhibitors of monoamine oxidase B (MAO-B) and catechol-O-methyltransferase (COMT) are
major strategies to reduce levodopa degradation and thus to increase and prolong its effect …

Digital mobility measures: a window into real‐world severity and progression of Parkinson's disease

A Mirelman, J Volkov, A Salomon, E Gazit… - Movement …, 2024 - Wiley Online Library
Background Real‐world monitoring using wearable sensors has enormous potential for
assessing disease severity and symptoms among persons with Parkinson's disease (PD) …

On the use of wearable sensors as mobility biomarkers in the marketing authorization of new drugs: a regulatory perspective

M Viceconti, M Tome, W Dartee, I Knezevic… - Frontiers in …, 2022 - frontiersin.org
The loss of mobility is a common trait in multiple health conditions (eg, Parkinson's disease)
and is associated with reduced quality of life. In this context, being able to monitor mobility in …

Sarcopenia screening based on the assessment of gait with inertial measurement units: a systematic review

JL Perez-Lasierra, M Azpíroz-Puente… - BMC geriatrics, 2024 - Springer
Background Gait variables assessed by inertial measurement units (IMUs) show promise as
screening tools for aging-related diseases like sarcopenia. The main aims of this systematic …

Reverse engineering of digital measures: inviting patients to the conversation

I Clay, N Peerenboom, DE Connors, S Bourke… - Digital …, 2023 - karger.com
Background: Digital measures offer an unparalleled opportunity to create a more holistic
picture of how people who are patients behave in their real-world environments, thereby …

Digital endpoints in clinical trials of Alzheimer's disease and other neurodegenerative diseases: challenges and opportunities

AK Brem, S Kuruppu, C de Boer, M Muurling… - Frontiers in …, 2023 - frontiersin.org
Alzheimer's disease (AD) and other neurodegenerative diseases such as Parkinson's
disease (PD) and Huntington's disease (HD) are associated with progressive cognitive …

A unified framework for the measurement of mobility in older persons

MK Beauchamp, Q Hao, A Kuspinar… - Age and …, 2023 - academic.oup.com
Mobility is often referred to as a 'sixth vital sign'because of its ability to predict critical health
outcomes in later adulthood. In the World Health Organization (WHO) World Report on …